Cancer epigenetics: breakthrough in ID’ing target genes - Cancer is usually attributed to faulty genes, but growing evidence from the field of cancer epigenetics indicates a key role for the gene "silencing" proteins that stably turn genes off inside the cell nucleus. A new study from Rice University and Baylor College of Medicine promises to speed research in the field by rapidly identifying the genes that epigenetic proteins can target for silencing. Original reference: J. Zeng et al, Nucl. Acids Res. (2012) doi: 10.1093/nar/gks209